Role of the RAS in Pancreatic Cancer

E-ISSN： 1873-5576|11|4|412-420

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.4, 2011-05, pp. : 412-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of adjuvant therapy for pancreatic cancer

By Hartley Mark Ghaneh Paula Sutton Robert Neoptolemos John P Magee Conor J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2001-01 ,pp. : 87-107

Informa Healthcare

Access to resources Recommend Favorite

Role of platinum agents in the management of advanced pancreatic cancer

By Saif Muhammad Wasif Kim Richard

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2719-2727

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic cancer: the evolving role of systemic therapy

By El-Rayes Basil F Adsay N Volkan Philip Philip A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1939-1947

Informa Healthcare

Access to resources Recommend Favorite

Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 811-828

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Receptor-Blocking Agents: Potential Role in Pancreatic Cancer

By Greenway B.A.

Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. : 161-163

Adis International

Access to resources Recommend Favorite